Navigation Links
Biotech Pioneer William J. Rutter to Deliver Keynote at 2008 RAPS Horizons Conference
Date:2/18/2008

ROCKVILLE, Md., Feb. 18 /PRNewswire-USNewswire/ --- Biotech pioneer William J. Rutter, PhD, will deliver a keynote speech at the 2008 RAPS Horizons Conference & Exhibition in San Francisco next month, the Regulatory Affairs Professionals Society (RAPS) has announced.

Rutter, Chairman and CEO of Synergenics LLC and co-founder of biotech industry leader Chiron, will stimulate fresh and relevant perspectives on the regulatory implications of advances in biological and medical science that are driving new products and individually-oriented treatment strategies.

Among the issues Rutter will address:

-- Individualized cancer drug therapy

-- Cancer vaccines

-- Genetic-based therapy

-- Immunological control of disease via administered antibodies or vaccines

-- Stem cell therapy

"Dr. Rutter's unique experience with the rapidly shifting nature of science and healthcare products will provide us with crucial insight into evolving treatment regimens/protocols and regulatory strategies," said RAPS Executive Director Sherry L. Keramidas, PhD, CAE.

Under Rutter's leadership, Chiron placed a major emphasis on detection, prevention and treatment of infectious diseases. With Merck, Chiron developed a Hepatitis B vaccine, based on the Hepatitis B pseudoparticles from yeast. Rutter's commitment to funding research on important diseases led to two of Chiron's most enduring achievements: the cloning and first sequencing of the HIV genome in 1984, and the discovery, sequencing and cloning of the hepatitis C virus in 1987.

Keramidas emphasized the commonalities of innovation across various healthcare product lines, including devices, drugs and biotechnology, and the need to utilize the most recent science to discover new treatments and to bring these treatments to consumers safely and more efficiently.

Additionally, Keramidas said that regulatory professionals are increasingly working in more than one of these product areas, often focusing on a wide array of products launched in a number of regions worldwide.

"Our members are working across product lines and across the globe. Dr. Rutter's breakthroughs and scientific leadership are instructional for all regulatory professionals," said Keramidas.

The 2008 RAPS Horizons Conference & Exhibition, scheduled 26-28 March at the Fairmont San Francisco, is expected to draw hundreds of scientists, regulatory leaders and professionals from the biotechnology, pharmaceutical and medical device industries, government, academia, research and clinical organizations.

For more information or to register for Horizons, visit the RAPS website, http://www.raps.org/horizons.

About RAPS

The Regulatory Affairs Professionals Society (RAPS) guides and supports individuals--from industry, government, academia, research and clinical organizations--to bring life-saving and life-enhancing products to the global marketplace quickly and safely.

Founded in 1976 and operating outside the political arena, RAPS provides a neutral forum on emerging science and global regulatory challenges, offering personal and professional resources to help regulatory professionals continuously improve and work smarter, faster and in compliance with regulatory models.

RAPS established the regulatory profession worldwide and brings knowledge and progress to it. By identifying s, developing professional certification, and providing educational and networking opportunities, RAPS supports professionals throughout the healthcare product lifecycle. http://www.raps.org


'/>"/>
SOURCE Regulatory Affairs Professionals Society (RAPS)
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
3. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
4. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
5. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
6. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
7. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
8. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
9. Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
10. Favrille CEO to Present at NewsMakers in the Biotech Industry Investment Conference
11. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. ... San Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, ... government officials from around the world to address key issues in device compliance, quality ...
(Date:10/11/2017)... TX (PRWEB) , ... October 11, 2017 , ... ... August compared the implantation and pregnancy rates in frozen and fresh in ... contribution of progesterone and maternal age to IVF success. , After comparing the ...
(Date:10/10/2017)... California (PRWEB) , ... October 10, 2017 , ... Dr. ... speaking at his local San Diego Rotary Club. The event entitled ... Diego, CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by ...
(Date:10/9/2017)... 2017  BioTech Holdings announced today identification and ... ProCell stem cell therapy prevents limb loss in ... demonstrated that treatment with ProCell resulted in more ... compared to standard bone marrow stem cell administration.  ... reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:3/30/2017)... March 30, 2017  On April 6-7, 2017, Sequencing.com ... Genome hackathon at Microsoft,s headquarters in ... will focus on developing health and wellness apps that ... Hack the Genome is the first hackathon for ... world,s largest companies in the genomics, tech and health ...
(Date:3/27/2017)... 27, 2017  Catholic Health Services (CHS) has ... Society (HIMSS) Analytics for achieving Stage 6 on ... . In addition, CHS previously earned a place ... an electronic medical record (EMR). "HIMSS ... of EMR usage in an outpatient setting.  This ...
Breaking Biology News(10 mins):